Immunotherapy With Racotumomab in Advanced Lung Cancer

Clinical trial NCT01460472 · UNKNOWN

Trial details

NCT number: NCT01460472
Sponsor: Recombio SL
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

NSCLC Lung Cancer, Non-small Cell

Start date: 2010-09-01
Primary completion: 2016-09-01
Enrollment: 1082

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.